Rigel Pharmaceuticals | RIGL - Stock

Stock Price
29.48
Daily Change
-0.15 -0.51%
Monthly
-13.68%
Yearly
49.64%
Q1 Forecast
33.68

Rigel Pharmaceuticals reported $13.3M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Amgen USD 6.22B 121M Dec/2025
Anika Therapeutics USD 16.28M 638K Sep/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
AstraZeneca USD 6.59B 126M Sep/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Daiichi Sankyo JPY 608.55B 93.64B Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Halozyme Therapeutics USD 176.48M 9.32M Dec/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Intrexon USD 287K 68K Dec/2022
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Karyopharm Therapeutics USD 3.97M 1.03M Sep/2025
Ligand Pharmaceuticals USD 9.13M 2.77M Dec/2025
MacroGenics USD 8.75M 530K Sep/2025
Neurocrine Biosciences USD 69M 300K Dec/2025
Pfizer USD 11.47B 201M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Veracyte USD 20.55M 219K Dec/2025